Balance between Hyperinflammation and Immunosuppression in Sepsis

Hemang Yadav, Rodrigo Cartin-Ceba

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sepsis is a major cause of morbidity and mortality among hospitalized patients and the leading cause of death among patients admitted to intensive care units. The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways. These pathways are concurrent, starting early in the course of sepsis. Given the high burden of morbidity and mortality associated with sepsis, there is an increasing interest in immunomodulatory therapies targeted at improving outcomes in sepsis. This review will summarize current understanding about the balance between hyperinflammation and immunosuppression in sepsis and discuss the role of potential therapies to modulate these responses.

Original languageEnglish (US)
Pages (from-to)42-50
Number of pages9
JournalSeminars in Respiratory and Critical Care Medicine
Volume37
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Immunosuppression
Sepsis
Morbidity
Immunomodulation
Mortality
Intensive Care Units
Cause of Death
Anti-Inflammatory Agents

Keywords

  • glucocorticoid
  • immunology
  • immunosuppression
  • sepsis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Balance between Hyperinflammation and Immunosuppression in Sepsis. / Yadav, Hemang; Cartin-Ceba, Rodrigo.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 37, No. 1, 01.02.2016, p. 42-50.

Research output: Contribution to journalArticle

Yadav, Hemang ; Cartin-Ceba, Rodrigo. / Balance between Hyperinflammation and Immunosuppression in Sepsis. In: Seminars in Respiratory and Critical Care Medicine. 2016 ; Vol. 37, No. 1. pp. 42-50.
@article{682bb25c06f24e8ca791e2f28b9a2151,
title = "Balance between Hyperinflammation and Immunosuppression in Sepsis",
abstract = "Sepsis is a major cause of morbidity and mortality among hospitalized patients and the leading cause of death among patients admitted to intensive care units. The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways. These pathways are concurrent, starting early in the course of sepsis. Given the high burden of morbidity and mortality associated with sepsis, there is an increasing interest in immunomodulatory therapies targeted at improving outcomes in sepsis. This review will summarize current understanding about the balance between hyperinflammation and immunosuppression in sepsis and discuss the role of potential therapies to modulate these responses.",
keywords = "glucocorticoid, immunology, immunosuppression, sepsis",
author = "Hemang Yadav and Rodrigo Cartin-Ceba",
year = "2016",
month = "2",
day = "1",
doi = "10.1055/s-0035-1570356",
language = "English (US)",
volume = "37",
pages = "42--50",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Balance between Hyperinflammation and Immunosuppression in Sepsis

AU - Yadav, Hemang

AU - Cartin-Ceba, Rodrigo

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Sepsis is a major cause of morbidity and mortality among hospitalized patients and the leading cause of death among patients admitted to intensive care units. The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways. These pathways are concurrent, starting early in the course of sepsis. Given the high burden of morbidity and mortality associated with sepsis, there is an increasing interest in immunomodulatory therapies targeted at improving outcomes in sepsis. This review will summarize current understanding about the balance between hyperinflammation and immunosuppression in sepsis and discuss the role of potential therapies to modulate these responses.

AB - Sepsis is a major cause of morbidity and mortality among hospitalized patients and the leading cause of death among patients admitted to intensive care units. The immune response in sepsis is characterized by the activation of both proinflammatory and anti-inflammatory pathways. These pathways are concurrent, starting early in the course of sepsis. Given the high burden of morbidity and mortality associated with sepsis, there is an increasing interest in immunomodulatory therapies targeted at improving outcomes in sepsis. This review will summarize current understanding about the balance between hyperinflammation and immunosuppression in sepsis and discuss the role of potential therapies to modulate these responses.

KW - glucocorticoid

KW - immunology

KW - immunosuppression

KW - sepsis

UR - http://www.scopus.com/inward/record.url?scp=84956474298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956474298&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1570356

DO - 10.1055/s-0035-1570356

M3 - Article

C2 - 26820273

AN - SCOPUS:84956474298

VL - 37

SP - 42

EP - 50

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 1

ER -